The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...

News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been ...

WuXi Biologics employees have once again exemplified their deep-rooted commitment to the local community, delivering impactful support to St. Vincent de Paul Dundalk through their fourth annual ...

WuXi 2269-1.25%decrease ... The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late ...

Dundalk town centre is cordoned off by Gardai following a bomb scare at the courthouse. The court was making preparations for ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop multi-payload antibody-drug conjugates. | A new weight-loss biotech launched ...

Meanwhile, WuXi has, since 2018, invested more than €1bn in a facility in Dundalk, near the border with Northern Ireland. Earlier this month the US House of Representatives passed a bill to ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...

WuXi Biologics Cayman Inc. will sell a vaccine ... while continuing to navigate geopolitical tensions. The site at Dundalk, Ireland, which has been under construction since 2019, was designed ...